| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Abbas E Kitabchi | Q62995074 |
| P2093 | author name string | John M Miles | |
| Guillermo E Umpierrez | |||
| Joseph N Fisher | |||
| P2860 | cites work | Thirty years of personal experience in hyperglycemic crises: diabetic ketoacidosis and hyperglycemic hyperosmolar state | Q24654164 |
| Syndromes of ketosis-prone diabetes mellitus | Q24655089 | ||
| Narrative Review: Ketosis-Prone Type 2 Diabetes Mellitus | Q28109642 | ||
| Risk factors for cerebral edema in children with diabetic ketoacidosis. The Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics | Q31921244 | ||
| Does bicarbonate therapy improve the management of severe diabetic ketoacidosis? | Q33813217 | ||
| Inflammatory mediators and modulation of blood-brain barrier permeability | Q33851290 | ||
| Management of hyperglycemic crises in patients with diabetes | Q33934250 | ||
| Diabetic ketoacidosis in children | Q34125364 | ||
| Diabetic ketoacidosis and hyperglycemic hyperosmolar nonketotic syndrome | Q34125370 | ||
| Nonspecific hyperamylasemia and hyperlipasemia in diabetic ketoacidosis: incidence and correlation with biochemical abnormalities | Q34512049 | ||
| Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance | Q34545877 | ||
| Hyperglycemic crises in adult patients with diabetes: a consensus statement from the American Diabetes Association | Q34585116 | ||
| Intracerebral crises during treatment of diabetic ketoacidosis | Q34624992 | ||
| Plasma acid-base patterns in diabetic ketoacidosis | Q34713258 | ||
| Insulin pump therapy: a meta-analysis | Q35094023 | ||
| Characteristics of diabetic ketoacidosis in older versus younger adults | Q35387190 | ||
| Diabetic ketoacidosis in infants, children, and adolescents: A consensus statement from the American Diabetes Association | Q36462555 | ||
| Nutritionist visits, diabetes classes, and hospitalization rates and charges: the Urban Diabetes Study | Q36711054 | ||
| Is a priming dose of insulin necessary in a low-dose insulin protocol for the treatment of diabetic ketoacidosis? | Q36945251 | ||
| Effects of free fatty acid availability, glucagon excess, and insulin deficiency on ketone body production in postabsorptive man | Q36989395 | ||
| Can serum beta-hydroxybutyrate be used to diagnose diabetic ketoacidosis? | Q37054023 | ||
| Insulin analogs versus human insulin in the treatment of patients with diabetic ketoacidosis: a randomized controlled trial | Q37235879 | ||
| Hormonal Interactions in the Regulation of Blood Glucose | Q38041120 | ||
| Diabetes in urban African-Americans. I. Cessation of insulin therapy is the major precipitating cause of diabetic ketoacidosis | Q39369452 | ||
| Hyperglycemic crises in urban blacks | Q39442186 | ||
| Liver glycogen metabolism: an overview | Q39508527 | ||
| Fluid resuscitation in diabetic emergencies--a reappraisal | Q39593929 | ||
| Diabetic ketoacidosis. Induction of hypocalcemia and hypomagnesemia by phosphate therapy | Q39697566 | ||
| The effects of acid-base disturbances on cardiovascular and pulmonary function | Q39941567 | ||
| Glucose and ketone body kinetics in diabetic ketoacidosis | Q40207998 | ||
| Nonketotic hypertonicity in diabetes mellitus | Q40561261 | ||
| Phosphorus Deficiency and Hypophosphatemia | Q41229015 | ||
| Diabetic Ketoacidosis: Low-Dose Insulin Therapy by Various Routes | Q41274786 | ||
| Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis | Q42634572 | ||
| Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises | Q43637162 | ||
| The efficacy of low-dose versus conventional therapy of insulin for treatment of diabetic ketoacidosis | Q43731927 | ||
| Abdominal pain in patients with hyperglycemic crises | Q44012512 | ||
| Factors associated with adverse outcomes in children with diabetic ketoacidosis-related cerebral edema | Q44235972 | ||
| Ketosis-prone diabetes: dissection of a heterogeneous syndrome using an immunogenetic and beta-cell functional classification, prospective analysis, and clinical outcomes | Q44645494 | ||
| Diabetic ketoacidosis with intracerebral complications | Q44796626 | ||
| Fatal olanzapine-induced hyperglycemic ketoacidosis | Q44913346 | ||
| Treatment of diabetic ketoacidosis with subcutaneous insulin aspart | Q44995585 | ||
| Diabetic ketoacidosis charges relative to medical charges of adult patients with type I diabetes | Q45244982 | ||
| Proinflammatory cytokines in response to insulin-induced hypoglycemic stress in healthy subjects | Q46079608 | ||
| Severe hyperglycemic hyperosmolar nonketotic coma in a nondiabetic patient receiving aripiprazole | Q46603397 | ||
| Active use of cocaine: an independent risk factor for recurrent diabetic ketoacidosis in a city hospital | Q46925664 | ||
| Economic impact of diabetic ketoacidosis in a multiethnic indigent population: analysis of costs based on the precipitating cause | Q47401952 | ||
| Detailed diagnoses and procedures, National Hospital Discharge Survey, 1995. | Q50914202 | ||
| Short-term fasting is a mechanism for the development of euglycemic ketoacidosis during periods of insulin deficiency. | Q51600704 | ||
| Spurious laboratory values in diabetic ketoacidosis and hyperlipidemia. | Q53786278 | ||
| Barriers to improving diabetes care for blacks. | Q53858470 | ||
| Insulin resistance in diabetic ketoacidosis. | Q54511629 | ||
| Small doses of intramuscular insulin in the treatment of diabetic "coma". | Q54692084 | ||
| National standards for diabetes self-management education. | Q55710040 | ||
| Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosis | Q57159018 | ||
| Predisposing factors for the diabetic hyperosmolar state | Q60152881 | ||
| Euglycaemic diabetic ketoacidosis | Q67246133 | ||
| Abdominal pain in diabetic metabolic decompensation. Clinical significance | Q67508964 | ||
| Pseudonormoglycemia in diabetic ketoacidosis with elevated triglycerides | Q67982262 | ||
| Hypothermia in Diabetic Acidosis | Q69382107 | ||
| Bicarbonate therapy in severe diabetic ketoacidosis | Q70311163 | ||
| Diabetic ketoacidosis and infection: leukocyte count and differential as early predictors of serious infection | Q70326731 | ||
| Metabolic effects of low-dose insulin therapy on glucose metabolism in diabetic ketoacidosis | Q70408519 | ||
| A randomized study of phosphate therapy in the treatment of diabetic ketoacidosis | Q70434533 | ||
| A case of pituitary gigantism who had two episodes of diabetic ketoacidosis followed by complete recovery of diabetes | Q70462462 | ||
| Diabetic ketoacidosis during long-term treatment with continuous subcutaneous insulin infusion | Q70470643 | ||
| Differences in metabolic and hormonal milieu in diabetic- and alcohol-induced ketoacidosis | Q73946487 | ||
| Hypophosphatemia in the emergency department therapeutics | Q74087329 | ||
| Enhanced subclinical coagulation activation during diabetic ketoacidosis | Q74554507 | ||
| The use of alkali therapy in severe diabetic ketoacidosis | Q78432089 | ||
| Burden of hospitalizations primarily due to uncontrolled diabetes: implications of inadequate primary health care in the United States | Q79750542 | ||
| Diabetes management in correctional institutions | Q80423347 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivatives | Q6937225 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| hyperglycemia | Q271993 | ||
| diabetic ketoacidosis | Q877827 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 1335-43 | |
| P577 | publication date | 2009-07-01 | |
| P1433 | published in | Diabetes Care | Q5270111 |
| P1476 | title | Hyperglycemic crises in adult patients with diabetes | |
| P478 | volume | 32 |
| Q90116777 | A Case of Multifactorial Diabetic Ketoacidosis Acquired in the Intensive Care Unit: A Case Report |
| Q42172713 | A Paper-Based "Pop-up" Electrochemical Device for Analysis of Beta-Hydroxybutyrate. |
| Q54937165 | A Portulaca oleracea L. extract promotes insulin secretion via a K+ATP channel dependent pathway in INS-1 pancreatic β-cells. |
| Q64055598 | A Retrospective Study of Early vs Delayed Home Dose Basal Insulin in the Acute Management of Diabetic Ketoacidosis |
| Q39355218 | A Review of the Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitors: A Focus on Diabetic Ketoacidosis |
| Q53270487 | A bioelectronic system for insulin release triggered by ketone body mimicking diabetic ketoacidosis in vitro. |
| Q36818163 | A case of Takotsubo cardiomyopathy induced by accidental hypothermia and diabetic ketoacidosis |
| Q37683905 | A case of a woman with late-pregnancy-onset DKA who had normal glucose tolerance in the first trimester |
| Q48875466 | A quadruply-asymmetric sigmoid to describe the insulin-glucose relationship during intravenous insulin infusion |
| Q37051332 | A review of hypoglycaemia in a South African family practice setting |
| Q39137850 | Access to Care in the Wake of Hurricane Sandy, New Jersey, 2012. |
| Q34016108 | Acidosis: the prime determinant of depressed sensorium in diabetic ketoacidosis |
| Q42656674 | Active cocaine use does not increase the likelihood of hyperglycemic crisis. |
| Q94525989 | Acute Complications of Diabetes and its Predictors among Adult Diabetic Patients at Jimma Medical Center, Southwest Ethiopia |
| Q41403265 | Acute Elevated Glucose Promotes Abnormal Action Potential-Induced Ca2+ Transients in Cultured Skeletal Muscle Fibers |
| Q90293792 | Acute coronary syndrome and diabetic keto acidosis: the chicken or the egg? |
| Q97422158 | Acute mountain sickness induced diabetic ketoacidosis managed with hemodialysis: A case report |
| Q37712430 | Adherence to pediatric diabetic ketoacidosis guidelines by community emergency departments' providers |
| Q34463269 | Adult hyperglycemic crisis: a review and perspective |
| Q89535787 | Alisol A-24-acetate promotes glucose uptake via activation of AMPK in C2C12 myotubes |
| Q42292480 | An Exceptional Case of Diabetic Ketoacidosis. |
| Q36742373 | Analyzing the Chinese landscape in anti-diabetic drug research: leading knowledge production institutions and thematic communities |
| Q38097122 | Antibiotic resistance rates in causative agents of infections in diabetic patients: rising concerns. |
| Q30502892 | Assessment of the clinical outcome of a symptom-based outpatient hyperglycemia protocol |
| Q37140799 | Association between Serum Albumin Concentration and Ketosis Risk in Hospitalized Individuals with Type 2 Diabetes Mellitus. |
| Q37236907 | Association between hyperglycaemic crisis and long-term major adverse cardiovascular events: a nationwide population-based, propensity score-matched, cohort study |
| Q90289412 | Association of Serum Calcium Level with Waist Circumference and Other Biochemical Health-care Predictors among Patients with Type 2 Diabetes |
| Q64066100 | Association of socioeconomic status and DKA readmission in adults with type 1 diabetes: analysis of the US National Readmission Database |
| Q38076320 | Atypical antipsychotics and diabetic ketoacidosis: a review |
| Q43164772 | Atypical diabetic ketoacidosis: case report |
| Q35657513 | Bioactive Metabolites from Mangrove Endophytic Fungus Aspergillus sp. 16-5B |
| Q39171088 | Blood Ketones: Measurement, Interpretation, Limitations, and Utility in the Management of Diabetic Ketoacidosis |
| Q34833819 | Cancer history, bandemia, and serum creatinine are independent mortality predictors in patients with infection-precipitated hyperglycemic crises |
| Q35839470 | Cases: "safety" technology: a hidden cause of diabetic ketoacidosis |
| Q99562527 | Characteristics and Long -Term Outcomes of Patients Hospitalized for Diabetic Ketoacidosis |
| Q91875422 | Characteristics and clinical course of type 1 diabetes mellitus related to anti-programmed cell death-1 therapy |
| Q92661961 | Characteristics of hyperglycemic crises in an adult population in a teaching hospital in Colombia |
| Q92604075 | Characterization of variable presentations of diabetic ketoacidosis based on blood ketone levels and major society diagnostic criteria: a new view point on the assessment of diabetic ketoacidosis |
| Q93083370 | Choice of crystalloid fluid in the treatment of hyperglycemic emergencies: a systematic review protocol |
| Q92077309 | Circulating osteocalcin: A potential predictor of ketosis in type 2 diabetes |
| Q36263795 | Clinical Characteristics of Diabetic Ketoacidosis in Children with Newly Diagnosed Type 1 Diabetes in Addis Ababa, Ethiopia: A Cross-Sectional Study. |
| Q35918125 | Clinical Profile of Diabetic Ketoacidosis: A Prospective Study in a Tertiary Care Hospital |
| Q36921788 | Clinical and Biochemical Characteristics of Diabetes Ketoacidosis in a Tertiary Hospital in Riyadh |
| Q64059887 | Clinical characteristics and outcomes of care in adult patients with diabetic ketoacidosis: A retrospective study from a tertiary diabetes center in Thailand |
| Q89947122 | Clinical characteristics and outcomes of patients with end-stage renal disease hospitalized with diabetes ketoacidosis |
| Q34523662 | Clinical characteristics of hyperglycemic crises in patients without a history of diabetes |
| Q38273849 | Clinical characteristics of patients with diabetic ketoacidosis at the Intensive Care Unit of a University Hospital |
| Q47822068 | Clinical inertia causing new or progression of diabetic retinopathy in type 2 diabetes: A retrospective cohort study. |
| Q98775964 | Clinical profile and outcomes in COVID-19 patients with diabetic ketoacidosis: A systematic review of literature |
| Q40881099 | Clinical profile of diabetic ketoacidosis in tertiary hospitals in China: a multicentre, clinic-based study |
| Q36548147 | Clinical significance of troponin elevations in acute decompensated diabetes without clinical acute coronary syndrome |
| Q59284918 | Clinical utility of Abbott Precision Xceed Pro® ketone meter in diabetic patients |
| Q91779569 | Closing the Mortality Gap in Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State: Implications of a Clinical Decision Support App |
| Q26741423 | Coadjuvants in the Diabetic Complications: Nutraceuticals and Drugs with Pleiotropic Effects |
| Q38680333 | Combination Immunotherapy for Type 1 Diabetes |
| Q55476396 | Comment on “DKA-Induced Takotsubo Cardiomyopathy in Patient with Known HOCM”. |
| Q28821013 | Community water fluoridation predicts increase in age-adjusted incidence and prevalence of diabetes in 22 states from 2005 and 2010 |
| Q47569793 | Comparison of Computer-Guided Versus Standard Insulin Infusion Regimens in Patients With Diabetic Ketoacidosis |
| Q55407704 | Comparison of Two Intravenous Insulin Titration Methods in Hyperglycemic Crisis. |
| Q41544126 | Comparison of a 'two-bag system' versus conventional treatment protocol ('one-bag system') in the management of diabetic ketoacidosis |
| Q90053270 | Comparison of bicarbonate values from venous blood gas and chemistry panels measured at the time of diagnosis and resolution of diabetes ketoacidosis |
| Q64052233 | Concurrent presentation of thyroid storm and diabetic ketoacidosis: a systematic review of previously reported cases |
| Q38392108 | Correction of hypovolemia with crystalloid fluids: Individualizing infusion therapy. |
| Q55555546 | Cytoprotective Roles of a Novel Compound, MHY-1684, against Hyperglycemia-Induced Oxidative Stress and Mitochondrial Dysfunction in Human Cardiac Progenitor Cells. |
| Q33168583 | DKA-Induced Takotsubo Cardiomyopathy in Patient with Known HOCM. |
| Q36608066 | Description of the sphingolipid content and subspecies in the diabetic cornea |
| Q35892444 | Descriptive data on cardiovascular and metabolic risk factors in ambulatory and non-ambulatory adults with cerebral palsy. |
| Q64263074 | Design, synthesis and biological activity evaluation of a new class of 2,4-thiazolidinedione compounds as insulin enhancers |
| Q44711580 | Development and implementation of a hyperglycemic emergency protocol |
| Q37130526 | Diabetes in the Emergency Department and Hospital: Acute Care of Diabetes Patients. |
| Q34344884 | Diabetes mellitus and electrolyte disorders. |
| Q59103611 | Diabetic Complications among Adult Diabetic Patients of a Tertiary Hospital in Northeast Ethiopia |
| Q40982466 | Diabetic Ketoacidosis Among Patients Treated With Continuous Subcutaneous Insulin Infusion |
| Q61448079 | Diabetic Ketoacidosis Post Bariatric Surgery |
| Q36362817 | Diabetic Myopathy and Mechanisms of Disease |
| Q38740284 | Diabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia |
| Q92917952 | Diabetic ketoacidosis in patients with type 2 diabetes treated with sodium glucose co-transporter 2 inhibitors versus other antihyperglycemic agents: An observational study of four US administrative claims databases |
| Q35467563 | Diabetic ketoacidosis in the setting of HNF1A-maturity onset diabetes of the young |
| Q41404715 | Diabetic ketoacidosis producing extreme hyperkalemia in a patient with type 1 diabetes on hemodialysis |
| Q42320435 | Diabetic ketoacidosis: Treatment in the intensive care unit or general medical/surgical ward? |
| Q33601593 | Diabetic ketoacidosis: a challenging diabetes phenotype |
| Q38151251 | Diabetic ketoacidosis: an overlooked child killer in sub-Saharan Africa? |
| Q41836281 | Diabetic ketoalkalosis after steroid pulse therapy in a patient with pancreas transplant rejection |
| Q34626897 | Diagnostic accuracy of point-of-care testing for diabetic ketoacidosis at emergency-department triage: {beta}-hydroxybutyrate versus the urine dipstick |
| Q84364257 | Dynamics of blood electrolytes in repeated hyper- and/or hypoglycaemic events in patients with type 1 diabetes |
| Q61448560 | Early late oral nutrition in patients with diabetic ketoacidosis admitted to a medical intensive care unit |
| Q33828997 | Early pregnancy urinary biomarkers of fatty acid and carbohydrate metabolism in pregnancies complicated by gestational diabetes |
| Q60910744 | Effect of Bolus Insulin Administration Followed by a Continuous Insulin Infusion on Diabetic Ketoacidosis Management |
| Q40543248 | Effect of Repetitive Glucose Spike and Hypoglycaemia on Atherosclerosis and Death Rate in Apo E-Deficient Mice. |
| Q37205754 | Effect of glycemic control on the risk of pancreatic cancer: A nationwide cohort study |
| Q35792427 | Effectiveness of Insulin Glargine on Recovery of Patients with Diabetic Ketoacidosis: A Randomized Controlled Trial |
| Q61448557 | Effects of diabetic ketoacidosis in the respiratory system |
| Q33751560 | Effects of intravenous glucose load on insulin secretion in patients with ketosis-prone diabetes during near-normoglycemia remission |
| Q47770648 | Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial |
| Q48076623 | Efficacy of metformin-based oral antidiabetic drugs is not inferior to insulin glargine in newly diagnosed type 2 diabetic patients with severe hyperglycemia after short-term intensive insulin therapy |
| Q36464964 | Elevated extracellular glucose and uncontrolled type 1 diabetes enhance NFAT5 signaling and disrupt the transverse tubular network in mouse skeletal muscle |
| Q38599739 | Emergency Neurological Life Support: Acute Non-traumatic Weakness |
| Q47771167 | Emergency Neurological Life Support: Acute Non-traumatic Weakness |
| Q38042829 | Emergency neurological life support: acute non-traumatic weakness. |
| Q85331689 | Emodin protects against diabetic cardiomyopathy by regulating the AKT/GSK-3β signaling pathway in the rat model |
| Q64061804 | Empagliflozin-induced Diabetic Ketoacidosis Unmasking a Type 1 Diabetes Diagnosis |
| Q50131260 | End-Stage Renal Disease Increases Rates of Adverse Glucose Events When Treating Diabetic Ketoacidosis or Hyperosmolar Hyperglycemic State |
| Q38676223 | Endocrine Emergencies With Neurologic Manifestations |
| Q56889222 | Endocrine toxicity of cancer immunotherapy targeting immune checkpoints |
| Q38364795 | Epidemiological Perspectives of Diabetes |
| Q48330036 | Euglycaemic diabetic ketoacidosis in patients using sodium-glucose co-transporter 2 inhibitors. |
| Q88431005 | Euglycaemic ketoacidosis in a postoperative Whipple patient using canaglifozin |
| Q64904716 | Euglycemic Diabetic Ketoacidosis Secondary to Dapagliflozin in a Patient with Colon Malignancy. |
| Q89738326 | Euglycemic Diabetic Ketoacidosis in Pregnancy |
| Q90151696 | Euglycemic Diabetic Ketoacidosis in Pregnancy: A Case Report and Review of Current Literature |
| Q37055206 | Euglycemic Diabetic Ketoacidosis in a 27 year-old female patient with type-1-Diabetes treated with sodium-glucose cotransporter-2 (SGLT2) inhibitor Canagliflozin |
| Q37192990 | Euglycemic Diabetic Ketoacidosis in a Patient with Cocaine Intoxication |
| Q92102401 | Euglycemic Diabetic Ketoacidosis in a Young Pregnant Woman Precipitated by Urinary Tract Infection |
| Q58589690 | Euglycemic Diabetic Ketoacidosis in the ICU: 3 Case Reports and Review of Literature |
| Q41974880 | Euglycemic Diabetic Ketoacidosis with Persistent Diuresis Treated with Canagliflozin |
| Q35809523 | Euglycemic Diabetic Ketoacidosis, a Misleading Presentation of Diabetic Ketoacidosis. |
| Q35973255 | Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium-Glucose Cotransporter 2 Inhibition |
| Q93128478 | Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitor use: a case report and review of the literature |
| Q92857166 | Euglycemic diabetic ketoacidosis caused by canagliflozin: a case report |
| Q92981737 | Euglycemic diabetic ketoacidosis due to a strict low-carbohydrate diet during treatment with sodium-glucose cotransporter 2 inhibitors |
| Q41405074 | Euglycemic diabetic ketoacidosis: a diagnostic and therapeutic dilemma |
| Q91965702 | Evaluation of Nova StatStrip and FreeStyle Precision Pro blood ketone tests using 3-hydroxybutyrate doped samples |
| Q42152099 | Evaluation of Ward Management of Diabetic Ketoacidosis |
| Q84644167 | Evaluation of cytokines and hormones in dogs before and after treatment of diabetic ketoacidosis and in uncomplicated diabetes mellitus |
| Q36843908 | Evaluation of safety of insulin degludec on undergoing total colonoscopy using continuous glucose monitoring |
| Q47943116 | Evaluation of the sub-chronic toxicity profile of the corm of Xanthosoma sagittifolium on hematology and biochemistry of alloxan-induced diabetic Wistar rats |
| Q50911029 | Evaluation of the treatment of diabetic ketoacidosis in the medical intensive care unit. |
| Q64056252 | Excessive Sodium Bicarbonate Infusion May Result in Osmotic Demyelination Syndrome During Treatment of Diabetic Ketoacidosis: A Case Report |
| Q89586013 | First User Experiences With a Novel Touchscreen-Based Insulin Pump System in Daily Life of Patients With Type 1 Diabetes Experienced in Insulin Pump Therapy |
| Q47705540 | Fluid balance concepts in medicine: Principles and practice |
| Q35222078 | Frequency and associated risk factors of recurrent diabetic ketoacidosis among Saudi adolescents with type 1 diabetes mellitus |
| Q35978530 | Fulminant type 1 diabetes mellitus |
| Q41564126 | Generalized Status Epilepticus in a Patient with Acute-onset Type 1 Diabetes Mellitus Associated with Severe Kidney Dysfunction: A Case Report and Literature Review |
| Q50752532 | Guidelines for management of diabetic ketoacidosis: time to revise? |
| Q37529207 | HbA1c as a Screening tool for Ketosis in Patients with Type 2 Diabetes Mellitus |
| Q92497645 | High drug-loading gold nanoclusters for responsive glucose control in type 1 diabetes |
| Q52680499 | Honey as a Potential Natural Antioxidant Medicine: An Insight into Its Molecular Mechanisms of Action. |
| Q90331201 | Hospital admissions for hyperglycemic emergencies in young adults at an inner-city hospital |
| Q33616117 | How Does Ambient Air Temperature Affect Diabetes Mortality in Tropical Cities? |
| Q35145277 | How the impact of median neuropathy on sensorimotor control capability of hands for diabetes: an achievable assessment from functional perspectives |
| Q42135239 | How well do we need to control blood glucose before discharging DKA patients? A retrospective cohort study |
| Q51805046 | Hyperglycaemic hyperosmolar state. |
| Q92712724 | Hyperglycemia-induced seizures - Understanding the clinico- radiological association |
| Q55403038 | Hyperglycemic Crisis in an Anuric Peritoneal Dialysis Patient with Profound and Symptomatic Hypertonicity. |
| Q59796831 | Hyperglycemic Hyperosmolar State: A Pragmatic Approach to Properly Manage Sodium Derangements |
| Q49096120 | Hyperglycemic crisis in patients with diabetes mellitus |
| Q35747947 | Hyperglycemic hyperosmolar syndrome at the onset of type 2 diabetes mellitus in an adolescent male |
| Q26782019 | Hyperosmolar hyperglycemic state: a historic review of the clinical presentation, diagnosis, and treatment |
| Q37560416 | Hypertonicity: Clinical entities, manifestations and treatment |
| Q64229442 | Hypertriglyceridemia and Its Association with HbA1c Test: A Prospective Controlled Study |
| Q41791225 | Hypoglycemia is independently associated with multidimensional impairment in elderly diabetic patients |
| Q60948754 | Hypoglycemic Mechanism of the Berberine Organic Acid Salt under the Synergistic Effect of Intestinal Flora and Oxidative Stress |
| Q46643705 | Hypokalemia in diabetic ketoacidosis is less common than previously reported |
| Q42776108 | Hypokalemic paralysis as the presenting manifestation of diabetes in two patients |
| Q33594416 | Hypothyroidism among pediatric patients with type 1 diabetes mellitus, from patients' characteristics to disease severity |
| Q38742730 | Identification of highly potent α-glucosidase inhibitory and antioxidant constituents from Zizyphus rugosa bark: enzyme kinetic and molecular docking studies with active metabolites. |
| Q92744428 | Immune checkpoint inhibitor-induced Type 1 diabetes: a systematic review and meta-analysis |
| Q33706769 | Impact of creatinine methodology on glomerular filtration rate estimation in diabetes |
| Q38740505 | Impact of diabetic ketoacidosis management in the medical intensive care unit after order set implementation |
| Q61447270 | Improvement in renal prognosis with prompt hemodialysis in hyperosmolar hyperglycemic state-related rhabdomyolysis: A case report |
| Q92529128 | In the Search of Glycoside-Based Molecules as Antidiabetic Agents |
| Q34388533 | Incidence and characteristics of acute kidney injury in severe diabetic ketoacidosis |
| Q36424791 | Incidence and outcome of adults with diabetic ketoacidosis admitted to ICUs in Australia and New Zealand |
| Q38648121 | Incidence and prevalence of diabetic ketoacidosis (DKA) among adults with type 1 diabetes mellitus (T1D): a systematic literature review |
| Q38888168 | Incidence, recurrence and cost of hyperglycaemic crises requiring emergency treatment in Andalusia, Spain |
| Q42561164 | Infection, absent tachycardia, cancer history, and severe coma are independent mortality predictors in geriatric patients with hyperglycemic crises |
| Q58803433 | Inhibitory Effect of Extract on Hyperglycemia-Related Expression and Cancer Proliferation |
| Q38065105 | Initial combination with linagliptin and metformin in newly diagnosed type 2 diabetes and severe hyperglycemia |
| Q48759334 | Insulin administered by needle-free jet injection corrects marked hyperglycaemia faster in overweight or obese patients with diabetes |
| Q37082032 | Insulin therapy for the management of hyperglycemia in hospitalized patients |
| Q37409973 | Insulin-like growth factor-1 improves diabetic cardiomyopathy through antioxidative and anti-inflammatory processes along with modulation of Akt/GSK-3β signaling in rats |
| Q96954087 | Intractable hiccups as a rare gastrointestinal manifestation in severe endocrine and metabolic crisis: case report and review of the literature |
| Q38112094 | Intravenous sodium bicarbonate therapy in severely acidotic diabetic ketoacidosis |
| Q36265738 | Investigation of coordination and order in transcription regulation of innate and adaptive immunity genes in type 1 diabetes. |
| Q55378960 | Investigation of β-Sitosterol and Prangol Extracted from Achillea Tenoifolia Along with Whole Root Extract on Isolated Rat Pancreatic Islets. |
| Q92481302 | Is There Any Lower Limit of Serum Bicarbonate in Diabetic Ketoacidosis? |
| Q55069710 | Japanese Clinical Practice Guideline for Diabetes 2016. |
| Q34626509 | Joint British Diabetes Societies guideline for the management of diabetic ketoacidosis |
| Q36252564 | Ketoacidosis in a non-diabetic woman who was fasting during lactation |
| Q98892062 | Ketosis in patients undergoing medically supervised therapeutic fasting-results from an observational trial |
| Q46652313 | Letter to the editor concerning the article "Hyperglycemic crisis in patients with diabetes mellitus" |
| Q59132820 | Limb Ischemia in a Patient with Hyperosmolar Hyperglycemic State |
| Q92331651 | Lispro insulin and electrolyte supplementation for treatment of diabetic ketoacidosis in cats |
| Q28073491 | Long Noncoding RNAs in Metabolic Syndrome Related Disorders |
| Q99578838 | Management of Diabetic Ketoacidosis in Adults: A Narrative Review |
| Q59350116 | Management of Diabetic Ketoacidosis with Dengue Hemorrhagic Fever |
| Q38711143 | Management of Hyperglycemia and Diabetes in the Emergency Department |
| Q30234966 | Management of Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State |
| Q38233862 | Management of adult diabetic ketoacidosis |
| Q86214350 | Management of adult diabetic ketoacidosis |
| Q48938432 | Management of hyperglycemia in acute ischemic stroke |
| Q38176514 | Management of patients with type 1 diabetes in the hospital |
| Q42861409 | Managing diabetic ketoacidosis in non-intensive care unit setting: Role of insulin analogs |
| Q38719941 | Markedly increased incidence of critical illness in adults with Type 1 diabetes |
| Q55020080 | Metabolic Pathway Genes Associated with Susceptibility Genes to Coronary Artery Disease. |
| Q38545663 | Methodological Reporting Quality of Randomized Controlled Trials in 3 Leading Diabetes Journals From 2011 to 2013 Following CONSORT Statement: A System Review |
| Q50774759 | Models for enhancing competency-based training and contextual clinical decision making. |
| Q51310993 | Momilactone B Inhibits Ketosis In Vitro by Regulating the ANGPTL3-LPL Pathway and Inhibiting HMGCS2. |
| Q41866726 | Mulberry leaf alleviates streptozotocin-induced diabetic rats by attenuating NEFA signaling and modulating intestinal microflora |
| Q42208066 | Multiplicative surrogate standard deviation: a group metric for the glycemic variability of individual hospitalized patients |
| Q40629524 | National survey of the management of Diabetic Ketoacidosis (DKA) in the UK in 2014. |
| Q90703722 | Neural network-based model predictive control for type 1 diabetic rats on artificial pancreas system |
| Q47645007 | New onset diabetes after nivolumab treatment |
| Q43491632 | Novel aspect of ketone action: β-hydroxybutyrate increases brain synthesis of kynurenic acid in vitro. |
| Q50128365 | Occlusion Detection Time in Insulin Pumps at Two Different Basal Rates |
| Q50921668 | Optimisation of glycaemic control during episodes of severe/acute hyperglycaemia in patients with type 2 diabetes mellitus. |
| Q41883982 | Osmotic demyelination syndrome as the initial manifestation of a hyperosmolar hyperglycemic state |
| Q34498406 | Oxidative stress increases pulmonary vascular permeability in diabetic rats through activation of transient receptor potential melastatin 2 channels |
| Q64967256 | Peritoneal dialysis for the rescue in critical refractory metabolic acidosis in diabetic ketoacidosis. |
| Q49715547 | Pharmacokinetics, Tissue Distribution, and Elimination of Three Active Alkaloids in Rats after Oral Administration of the Effective Fraction of Alkaloids from Ramulus Mori, an Innovative Hypoglycemic Agent |
| Q38655885 | Population-based incidence of diabetic ketoacidosis in type 2 diabetes: medical claims data analysis in Japan. |
| Q58800699 | Post-mortem analysis of lactate concentration in diabetics and metformin poisonings |
| Q64948255 | Post-surgical Euglycemic Diabetic Ketoacidosis in a Patient on Empagliflozin in the Intensive Care Unit. |
| Q35847872 | Postmortem diagnosis of diabetes mellitus and its complications |
| Q38107343 | Practical approach to management of inpatient hyperglycemia in select patient populations |
| Q51243821 | Prediabetes Directly Deteriorates into Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic Syndrome Triggered by Acute Pancreatitis: A Case Report Illustrating a "Chicken and Egg" Paradigm in Ketosis-Prone Diabetes. |
| Q35802824 | Predictors and treatment outcome of hyperglycemic emergencies at Jimma University Specialized Hospital, southwest Ethiopia |
| Q37260421 | Prevalence of ketosis, ketonuria, and ketoacidosis during liberal glycemic control in critically ill patients with diabetes: an observational study. |
| Q88798020 | Preventable Diabetic Complications After a Cancer Diagnosis in Patients With Diabetes: A Population-Based Cohort Study |
| Q44562468 | Preventing diabetic ketoacidosis: do patients adhere to sick-day rules? |
| Q38160211 | Prevention of exercise-related injuries and adverse events in patients with type 2 diabetes |
| Q40246636 | Prolonged hypernatremia triggered by hyperglycemic hyperosmolar state with coma: A case report |
| Q97073327 | Protracted ketonaemia in hyperglycaemic emergencies in COVID-19: a retrospective case series |
| Q64098685 | Pseudomyocardial Infarction in a Patient with Severe Diabetic Ketoacidosis and Mild Hyperkalemia |
| Q42718198 | Randomized Controlled Study of Metformin and Sitagliptin on Long-term Normoglycemia Remission in African American Patients With Hyperglycemic Crises |
| Q35207909 | Randomized controlled trial of insulin supplementation for correction of bedtime hyperglycemia in hospitalized patients with type 2 diabetes |
| Q60707245 | Recomendaciones para el tratamiento farmacológico de la hiperglucemia en la diabetes tipo 2 |
| Q35179810 | Recurrent diabetic ketoacidosis in inner-city minority patients: behavioral, socioeconomic, and psychosocial factors |
| Q39032289 | Relationship between frequency of hypoglycemic episodes and changes in carotid atherosclerosis in insulin-treated patients with type 2 diabetes mellitus |
| Q46000846 | Repetitive hypoglycaemia increases serum adrenaline and induces monocyte adhesion to the endothelium in rat thoracic aorta. |
| Q97084245 | Reply to comments on Letter to the Editor - Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus |
| Q98289119 | Research of Epidemic Big Data Based on Improved Deep Convolutional Neural Network |
| Q47643223 | Resolution of ketoacidosis in children with new onset diabetes: Evaluation of various definitions |
| Q42112574 | Respiratory Failure in the Course of Treatment of Diabetic Ketoacidosis |
| Q26799264 | Respiratory failure in diabetic ketoacidosis |
| Q92482655 | Restoration of insulin receptor improves diabetic phenotype in T2DM mice |
| Q50687185 | Retrospective evaluation of hyperosmolar hyperglycemia in 66 dogs (1993-2008). |
| Q33789987 | Review of Evidence for Adult Diabetic Ketoacidosis Management Protocols. |
| Q98578049 | Rhabdomyolysis Induced Acute Kidney Injury in Hyperglycemic Hyperosmolar State Patient With New-Onset Diabetes: A Case Report |
| Q52577942 | Rich table but short life: Diffuse idiopathic skeletal hyperostosis in Danish astronomer Tycho Brahe (1546-1601) and its possible consequences. |
| Q93221847 | Risk factors and prevention strategies for diabetic ketoacidosis in people with established type 1 diabetes |
| Q34505059 | Risk factors for hospital-acquired ‘poor glycemic control’: a case–control study |
| Q41195717 | Risk factors for recurrent admissions with diabetic ketoacidosis: a case-control observational study |
| Q37242951 | Risk of death following admission to a UK hospital with diabetic ketoacidosis. |
| Q48291193 | SGLT-2 inhibitors and ketoacidosis: a disproportionality analysis in the World Health Organization's adverse drug reactions database. |
| Q38734956 | SGLT2-I in the Hospital Setting: Diabetic Ketoacidosis and Other Benefits and Concerns |
| Q38664223 | Sentinel visits in emergency department patients with diabetes mellitus as a warning sign for hyperglycemic emergencies |
| Q89456510 | Sepsis in Latent Autoimmune Diabetes in Adults with Diabetic Ketoacidosis: A Case Report |
| Q90250126 | Serum Sodium Concentration and Tonicity in Hyperglycemic Crises: Major Influences and Treatment Implications |
| Q35817331 | Severe Ketoacidosis (pH ≤ 6.9) in Type 2 Diabetes: More Frequent and Less Ominous Than Previously Thought. |
| Q34643272 | Severe diabetic ketoacidosis in combination with starvation and anorexia nervosa at onset of type 1 diabetes: a case report. |
| Q59100569 | Sodium bicarbonate therapy in patients with metabolic acidosis |
| Q35831426 | Sodium-Glucose Linked Transporter 2 (SGLT2) Inhibitors in the Management Of Type-2 Diabetes: A Drug Class Overview. |
| Q91970275 | Sodium-glucose co-transporter inhibitors as adjunctive treatment to insulin in type 1 diabetes: A review of randomized controlled trials |
| Q47825623 | Standardizing Clinically Meaningful Outcome Measures Beyond HbA1c for Type 1 Diabetes: A Consensus Report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, th |
| Q33554238 | Standards of medical care in diabetes--2010. |
| Q24632533 | Standards of medical care in diabetes--2012 |
| Q29620309 | Standards of medical care in diabetes--2013 |
| Q24186409 | Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis |
| Q24194201 | Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis |
| Q51743680 | Suboptimal extracellular pH values alter DNA damage response to induced double-strand breaks. |
| Q40792395 | Subsequent mortality after hyperglycemic crisis episode in the non-elderly: a national population-based cohort study. |
| Q90133300 | Substrate metabolism, hormone and cytokine levels and adipose tissue signalling in individuals with type 1 diabetes after insulin withdrawal and subsequent insulin therapy to model the initiating steps of ketoacidosis |
| Q93136603 | Sudden-onset Hypoglycemia Following Fluid Replacement in a Patient with Dapagliflozin-induced Diabetic Ketoacidosis Without Prior Insulin Use: Case Report |
| Q27316663 | Sugar and chromosome stability: clastogenic effects of sugars in vitamin B6-deficient cells |
| Q36129546 | Synthesis, in vitro evaluation and molecular docking studies of novel coumarin-isatin derivatives as α-glucosidase inhibitors |
| Q44876627 | Synthetic beta cells for fusion-mediated dynamic insulin secretion |
| Q64954964 | Temporal Trends in the Prevalence of Diabetes Decompensation (Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State) Among Adult Patients Hospitalized with Diabetes Mellitus: A Nationwide Analysis Stratified by Age, Gender, and Race. |
| Q64071324 | The Inflammatory and Hemostatic Cardiovascular Risk Markers During Acute Hyperglycemic Crisis in Type 1 and Type 2 Diabetes |
| Q28551039 | The Safety of a Conservative Fluid Replacement Strategy in Adults Hospitalised with Malaria |
| Q49936055 | The association between Toxoplasma gondii infection and hypertensive disorders in T2DM patients: a case-control study in the Han Chinese population |
| Q38227647 | The case for 0.9% NaCl: is the undefendable, defensible? |
| Q55035609 | The management of diabetic ketoacidosis at a rural regional hospital in KwaZulu-Natal. |
| Q35111547 | The management of diabetic ketoacidosis in children |
| Q50123365 | The process of incorporating insulin pumps into the everyday lives of people with Type 1 diabetes: A critical interpretive synthesis. |
| Q38012076 | The role of point-of-care β-hydroxybutyrate testing in the diagnosis of diabetic ketoacidosis: a review |
| Q37681082 | Thyroid Storm Precipitated by Diabetic Ketoacidosis and Influenza A: A Case Report and Literature Review |
| Q90094060 | Thyroid Storm and Diabetic Ketoacidosis Presenting to the Emergency Department |
| Q36314898 | Too much of a good thing: Part 2: Management of hyperosmolar hyperglycemic syndrome |
| Q40594919 | Too much of a good thing: management of diabetic ketoacidosis in adults |
| Q38378748 | Transitioning safely from intravenous to subcutaneous insulin |
| Q38422353 | Treating the most vulnerable and costly in diabetes |
| Q37732910 | Treatment of Diabetic Ketoacidosis (DKA)/Hyperglycemic Hyperosmolar State (HHS): Novel Advances in the Management of Hyperglycemic Crises (UK Versus USA). |
| Q55395055 | Trends in Diabetic Ketoacidosis Hospitalizations and In-Hospital Mortality - United States, 2000-2014. |
| Q90360219 | Trends in Hyperglycemic Crisis Hospitalizations and in- and out-of-Hospital Mortality in the Last Decade Based on Korean National Health Insurance Claims Data |
| Q28242092 | Type 1 diabetes through the life span: a position statement of the American Diabetes Association |
| Q98281000 | Ultrasound-modulated optical glucose sensing using a 1645 nm laser |
| Q57299919 | Unusual high blood glucose in ketoacidosis as first presentation of type 1 diabetes mellitus |
| Q35958600 | Update on diagnosis, pathogenesis and management of ketosis-prone Type 2 diabetes mellitus |
| Q38906041 | Update review of the safety of sodium-glucose cotransporter 2 inhibitors for the treatment of patients with type 2 diabetes mellitus |
| Q35894755 | Use of Serum Bicarbonate to Substitute for Venous pH in New-Onset Diabetes |
| Q59336862 | Use of sodium bicarbonate and blood gas monitoring in diabetic ketoacidosis: A review |
| Q38644283 | Utilisation of prehospital emergency medical services for hyperglycaemia: A community-based observational study. |
| Q34443076 | Utility of ketone measurement in the prevention, diagnosis and management of diabetic ketoacidosis. |
| Q55212915 | Validation of Predicting Hyperglycemic Crisis Death Score: A Risk Stratification Tool for Appropriate Disposition of Hyperglycemic Crisis Patients from the Emergency Department. |
| Q36579824 | Variation in use of intensive care for adults with diabetic ketoacidosis*. |
| Q40577527 | Vildagliptin-induced acute lung injury: a case report |
| Q44826430 | Vitamin D and vitamin A receptor expression and the proliferative effects of ligand activation of these receptors on the development of pancreatic progenitor cells derived from human fetal pancreas |
| Q33896894 | Volume depletion versus dehydration: how understanding the difference can guide therapy |
| Q90376300 | Zingerone (4-(4-hydroxy-3-methylphenyl) butan-2-one) protects against alloxan-induced diabetes via alleviation of oxidative stress and inflammation: Probable role of NF-kB activation |
| Q89276016 | [Acidosis without marked hyperglycemia : Euglycemic diabetic ketoacidosis associated with SGLT2-Inhibitors] |
| Q87858280 | [Diabetes emergencies] |
| Q53757550 | [Diabetic emergencies : Hypoglycemia, ketoacidotic and hyperglycemic hyperosmolar nonketotic coma]. |
| Q91626371 | [Study of acute inaugural ketosis-prone diabetes in a Hospital in Central-Eastern Tunisian] |
Search more.